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Metastatic leptomeningeal carcinomatosis is estimated to occur in 3% to 8% of solid carcinomas. The most
common causes of leptomeningeal carcinomatosis are breast cancer, lung cancer and malignant melanoma.
Leptomeningeal carcinomatosis associated with gastric cancer, especially in its early stages, is exceedingly rare. Its
presenting symptoms include headache, nauseaand seizures. In this report, we describe a case of leptomeningeal
metastasis that presented with early-stage gastric cancer. A 67-year-old woman with a history of early-stage gastric
cancer in remission was admitted to our hospital with 3 days of headache and nausea. Her gastric cancer had been
treated 29 months prior to presentation by a radical subtotal gastrectomy with a Billroth I anastomosis. She had an
uneventful recovery until she was diagnosed with metastases to the left axilla and neck 26 months after surgery.
Her presenting symptoms of headache and nausea prompted cytologic examination of the cerebrospinal fluid and
measurement of tumor markers, which revealed metastatic leptomeningeal carcinomatosis from her gastric cancer.
This report aims to raise awareness of the possibility that even early-stage gastric cancer can lead to leptomeningeal
carcinomatosis.
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Gastric cancer is one of the most commonly diagnosed
malignancies in Korea, and the third most common
cause of mortality [1]. Most patients with gastric cancer
eventually develop cachexia and peritoneal carcinomatosis
and die of multiple organ failure. Early gastric cancer is
defined as adenocarcinoma of the stomach confined to the
mucosa or submucosa, regardless of the presence of lymph
node metastasis [2]. Although the 5-year survival rate of
early gastric cancer exceeds 85% in most series [3], some
cases are associated with distant metastasis. Brain metasta-
sis of gastric cancer in particular is rare, and leptomeningeal
carcinomatosis is even less common. Leptomeningeal car-
cinomatosis is defined as the dissemination and growth of
cancer cells within the leptomeningeal space. Metastatic
leptomeningeal carcinomatosis is estimated to occur in 3%
to 8% of solid carcinomas [4]. In this report, we present a* Correspondence: yoonkiyoung@naver.com
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reproduction in any medium, provided the orrare case of early gastric cancer leading to leptomeningeal
carcinomatosis.Case presentation
A 69-year-old woman with a history of early gastric cancer
was admitted to our hospital with a 3-day history of general
weakness, headache and nausea. On physical examination
she was pale and appeared acutely ill, but was oriented to
person, place and time. Her vital signs were as follows:
blood pressure 130/75 mmHg, pulse rate 83 beats/min and
respiratory rate 20 breaths/min. She exhibited no focal
neurological signs, including abnormal reflexes, sensory
deficits, nystagmus or neck stiffness. Her conjunctivae were
pale and sclerae were anicteric. Breath sounds were clear
and heart sounds were regular and without murmur.
The patient had been diagnosed with early gastric cancer
29 months prior to presentation, and had undergone a
radical subtotal gastrectomy with Billroth I anastomosis
and D1+ lymphadenectomy (Figure 1). Histology performed
at the time had shown diffuse-type gastric adenocarcinoma
confined to the mucosa with the presence of signet ring
cells. No metastases were found in the 34 dissected lymph
nodes. Her postoperative course was uneventful. She visited. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The gastroscopy showed a slightly depressed legion
on gastric angle and posterior wall of the stomach.
Figure 2 Cytopathologic finding of cerebrospinal fluid reveals a
small nest in scattered lymphocytic background. This nest
consisted of atypical round epithelial cells with large hyperchromatic
nuclei (Papanicolaou stain, ×400).
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3 months and 6 months after surgery, and at 6-month
intervals thereafter. She also underwent gastric endoscopy
and abdominal computed tomography (CT) every 6 months.
There was no evidence of recurrence until 26 months after
surgery, when the patient complained of palpable masses in
her left neck and axilla. She subsequently underwent neck
CT, fluorine-18-fluorodeoxyglucose positron emission tom-
ography, and fine needle aspiration of the left supraclavicu-
lar lymph node. Neck CT showed enlargement of multiple
nodes in the left neck and axilla, including the left supracla-
vicular lymph node, and fine needle aspirate histology
showed metastatic adenocarcinoma. She was diagnosed
with recurrence of early gastric cancer and scheduled to re-
ceive systemic chemotherapy with leucovorin, fluorouracil
and oxaliplatin (FOLFOX-6). She received 100 mg/m2 oxa-
liplatin and 100 mg/m2 leucovorin on the first day of treat-
ment, followed by 2,400 mg/m2 of 5-fluorouracil on the
first and second days of treatment every 2 weeks. After four
cycles of chemotherapy, tumor response evaluation showed
that disease stability had been achieved, prompting a fifth
cycle of the same chemotherapy regimen.
She presented as an outpatient 7 days after completing
the fifth chemotherapy cycle, complaining of general weak-
ness, headache and nausea. A lumbar puncture was per-
formed, and analysis of the cerebrospinal fluid (CSF)
showed malignant cells (Figure 2), elevated protein, normal
glucose, and the presence of tumor markers carcinoem-
bryonic antigen and carbohydrate antigen19-9 She was
diagnosed with metastatic leptomeningeal carcinomatosis
of early gastric cancer and admitted to the hospital. On the
seventh day of admission, she complained of dyspnea and
her level of consciousness decreased, prompting intubationand admission to the intensive care unit. Symptomatic
treatment was initiated with steroids and mannitol. Unfor-
tunately, the patient died on the 20th day of admission.Discussion
Early gastric cancer is defined as adenocarcinoma con-
fined to the mucosa or submucosa (T1), irrespective of
lymph node metastasis [2]. Its excellent 5-year survival
rate, above 85% in most series, is attributable to the low
incidence of extragastric extension of the disease. Lymph
node metastasis is found in 1.9% to 7% of patients with
mucosal and 7.4% to 20.9% of patients with submucosal
invasion, and is associated with a worse prognosis [5,6].
The lymphatic and hematogenous extension of early gas-
tric cancer can be explained by the infiltration of lymphatic
and vascular drainage routes by malignant cells in the mu-
cosal and submucosal layers. The prognostic significance
of signet ring cells is controversial, with some authors
reporting a common association with lymph node me-
tastasis [7], and others reporting a better prognosis in
the presence of signet ring cells [8].
First reported in the 1870 s, leptomeningeal carcinoma-
tosis is most often caused by breast cancer, lung cancer
and malignant melanoma [9]. Gastric cancer rarely causes
leptomeningeal carcinomatosis; one study reported an in-
cidence of 0.06% of all gastric cancers [10]. The clinical
manifestations of leptomeningeal carcinomatosis are
neurologic in origin and therefore variable, such as head-
ache, nausea, vomiting and ataxia. The median time to
diagnosis of leptomeningeal carcinomatosis from the initial
cancer diagnosis had been reported between 76 days [11]
and 17 months [10].
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cytologic examination of the CSF in addition to imaging
studies such as gadolinium-enhanced magnetic resonance
imaging [12]. CSF findings include increased opening pres-
sure, pleocytosis, elevated protein concentration, decreased
glucose concentration and the presence of tumor markers,
such as carcinoembryonic antigen and carbohydrate anti-
gen19-9 in the case of gastric cancer. A definitive diagnosis
of leptomeningeal carcinomatosis can be established only by
documenting the presence of malignant cells in the CSF. Al-
though Wasserstrom et al. reported that the first CSF sam-
pling has a relatively low diagnostic sensitivity of 54%, with
repeated sampling this ratio increases up to 91% [13]. In
our patient, the first CSF cytology revealed malignant cells.
It has been reported that imaging studies are abnormal in
67% of patients with leptomeningeal carcinomatosis [4].
Although leptomeningeal carcinomatosis is extremely
rare in early gastric cancer [4], in South Korea it is most
often associated with poorly differentiated adenocarcinoma
with signet ring cell features [3]. Once leptomeningeal car-
cinomatosis develops from any primary cancer, prognosis
is poor and neurological symptoms reduce quality of life.
There is no standard treatment established for leptomenin-
geal carcinomatosis, although intrathecal chemotherapy is
preferred as most intravenous chemotherapy agents do not
penetrate the blood–brain barrier. Intraventricular chemo-
therapy with or without radiation is most commonly used
in treatment. Intrathecal chemotherapy most often com-
prises methotrexate, cytarabine, thiotepa and steroids. The
prolongation of survival afforded by intrathecal chemother-
apy in leptomeningeal carcinomatosis is a matter of debate.
Unfortunately, the prognosis of leptomeningeal carcinoma-
tosis complicating gastric cancer is worse than in other
solid cancers, with an overall median survival ranging from
4 to 7 weeks. [3,4]. However, a recent paper published in
2011 reported a more favorable outcome with triple com-
bination therapy comprising intrathecal chemotherapy,
whole brain irradiation and ventriculoperitoneal shunt
compared with combination therapy (intrathecal chemo-
therapy plus whole brain irradiation) and monotherapy
(intrathecal chemotherapy alone) [14].
Conclusion
In conclusion, leptomeningeal carcinomatosis associated
with gastric carcinoma is rare, especially in early stages
of gastric cancer, and carries a poor prognosis. New
neurological symptoms in patients with gastric cancer,
including early-stage, should alert physicians to evaluate
for nervous system involvement and promptly establish
diagnostic and therapeutic plans.
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